U.S. Senate bill targeting China's BGI, WuXi AppTec moves forward

WASHINGTON (Reuters) -- The U.S. Senate's homeland security committee voted on Wednesday to approve a bill that could restrict business with Chinese biotech companies like BGI and WuXi AppTec on national security grounds.

The bill is designed to keep Americans' personal health and genetic information from foreign adversaries. The bill has spurred deep concern among investors, driving a sell-off in the shares of WuXi AppTec when news of its introduction first reached Chinese markets last month.